Abstract:Bromodomains (BrDs), a conserved structural module in chromatin‐associated proteins, are well known for recognizing ε‐N‐acetyl lysine residues on histones. One of the most relevant BrDs is BRD4, a tandem bromodomain containing protein (BrD1 and BrD2) that plays a critical role in numerous diseases including cancer. Growing evidence shows that the two BrDs of BRD4 have different biological functions; hence selective ligands that can be used to study their functions are of great interest. Here, as a follow‐up of our previous work (Gacias et al., Chem Biol. 2014; 21:841–854), we first provide a detailed characterization study of the in silico rational design of Olinone as part of a series of five tetrahydro‐pyrido indole‐based compounds as BRD4 BrD1 inhibitors. Additionally, we investigated the molecular basis for Olinone's selective recognition by BrD1 over BrD2. Molecular dynamics simulations, free energy calculations and conformational analyses of the apo‐BRD4‐BrD1|2 and BRD4‐BrD1|2/Olinone complexes showed that Olinone's selectivity is facilitated by five key residues: Leu92 in BrD1|385 in BrD2 of ZA loop, Asn140|433, Asp144|His437 and Asp145|Glu438 of BC loop, and Ile146|Val49 of helix C. Furthermore, the difference in hydrogen bonds number and in mobility of the ZA and BC loops of the acetyl‐lysine binding site between BRD4 BrD1/Olinone and BrD2/Olinone complexes also contribute to the difference in Olinone's binding affinity and selectivity towards BrD1 over BrD2. Altogether, our computer‐aided molecular design techniques can effectively guide the development of small‐molecule BRD4 BrD1 inhibitors, explain their selectivity origin, and further open doors to the design of new therapeutically‐improved derivatives.This article is protected by copyright. All rights reserved.

Selectivity on-target of bromodomain chemical probes by structure-guided medicinal chemistry and chemical biology

A Chemical Toolbox for the Study of Bromodomains and Epigenetic Signaling

Fragment-based discovery of bromodomain inhibitors part 1: inhibitor binding modes and implications for lead discovery

Chemical Proteomic Profiling of Bromodomains Enables the Wide-Spectrum Evaluation of Bromodomain Inhibitors in Living Cells.

Structural and atropisomeric factors governing the selectivity of pyrimido-benzodiazipinones as inhibitors of kinases and bromodomains.

Selective inhibition of BET bromodomains

Targeting Bromodomain-Containing Proteins: Research Advances of Drug Discovery

Research Progress of Selective Small Molecule Bromodomain-Containing Protein 9 Inhibitors

Dual‐target inhibitors of bromodomain and extra‐terminal proteins in cancer: A review from medicinal chemistry perspectives

Recent Advances on Small-Molecule Bromodomain-Containing Histone Acetyltransferase Inhibitors.

Insight into the key interactions of bromodomain inhibitors based on molecular docking, interaction fingerprinting, molecular dynamics and binding free energy calculation.

Selective Mechanism of Inhibitors to Two Bromodomains of BRD4 Revealed by Multiple Replica Molecular Dynamics Simulations and Free Energy Analyses

Targeting bromodomains: epigenetic readers of lysine acetylation

A Theoretical Insight into Selectivity of Inhibitors Toward Two Domains of Bromodomain-Containing Protein 4 Using Molecular Dynamics Simulations

Targeting Bromodomain-Selective Inhibitors of BET Proteins in Drug Discovery and Development

In silico design and molecular basis for the selectivity of Olinone toward the first over the second bromodomain of BRD4

Targeting Epigenetic Reader and Eraser: Rational Design, Synthesis and in Vitro Evaluation of Dimethylisoxazoles Derivatives As BRD4/HDAC Dual Inhibitors

Epigenetic targets and drug discovery: part 1: histone methylation.

Selectivity Mechanism of Pyrrolopyridone Analogues Targeting Bromodomain 2 of Bromodomain-Containing Protein 4 from Molecular Dynamics Simulations

Chemoproteomics and Chemical Probes for Target Discovery

Discovery and characterization of small molecule inhibitors of the BET family bromodomains